Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Origin Materials Inc (NASDAQ: ORGN) closed at $0.41 down -6.75% from its previous closing price of $0.44. In other words, the price has decreased by -$6.75 from its previous closing price. On the day, 1.44 million shares were traded. ORGN stock price reached its highest trading level at $0.4493 during the session, while it also had its lowest trading level at $0.4131.
Ratios:
For a deeper understanding of Origin Materials Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 03 ’25 when Plavan Matthew T sold 150,000 shares for $0.55 per share. The transaction valued at 82,500 led to the insider holds 1,360,231 shares of the business.
MATT PLAVAN bought 150,000 shares of ORGN for $78,993 on Nov 03 ’25. On Aug 21 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 3,860 shares for $0.56 each. As a result, the insider received 2,177 and left with 689,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 62440008 and an Enterprise Value of 13773005. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.49 while its Price-to-Book (P/B) ratio in mrq is 0.21. Its current Enterprise Value per Revenue stands at 0.548 whereas that against EBITDA is -0.261.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.92, which has changed by -0.6044643 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.36, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -23.34%, while the 200-Day Moving Average is calculated to be -31.12%.
Shares Statistics:
For the past three months, ORGN has traded an average of 1.06M shares per day and 690090 over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 136.50M. Insiders hold about 9.69% of the company’s shares, while institutions hold 10.87% stake in the company. Shares short for ORGN as of 1764288000 were 3900857 with a Short Ratio of 3.69, compared to 1761868800 on 3189118. Therefore, it implies a Short% of Shares Outstanding of 3900857 and a Short% of Float of 2.6199998.
